Table 3.
Summary statistics for paired test results comparing alfaxalone-midazolam mixtures across key variables and covariables
| Differences between AM mixtures | AM40 | AM10 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Min | Median | Max | SD | Min | Median | Max | SD | Min | Median | Max | SD |
| Total volume injected (mL) | −4.05 | −2.25 | −1.31 | 0.94087 | 0.64 | 1.12 | 1.89 | 0.4297 | 1.95 | 3.34 | 5.94 | 1.362 |
| Quality score | −1 | 0 | 3 | 1.19 | 3 | 4 | 4 | 0.414 | 1 | 4 | 4 | 1.11 |
| SSMV (mL/min) | −334 | −4.005 | 160 | 126.18 | 217 | 476.5 | 835 | 156.06 | 373 | 528.8 | 840 | 133.21 |
| Duration of SSMV (min) | −15.5 | 0 | 11.5 | 6.854 | 4.5 | 20 | 20 | 4.9917 | 8.5 | 20 | 20 | 3.7228 |
| AMV (mL) | −9,000 | 160 | 3,000 | 3,970 | 2,000 | 9,500 | 20,000 | 3,880 | 8,000 | 11,000 | 20,000 | 2,850 |
| Side effects score | −2 | 0 | 1 | 0.91 | 0 | 1 | 2 | 0.845 | 0 | 1 | 3 | 0.986 |
| Duration of anesthesia (min) | −97 | −10 | 52 | 38.596 | 46 | 88 | 147 | 29.28 | 52 | 94 | 179 | 39.846 |
| Time to start (min) | −50 | −3 | 20 | 17.7 | 3 | 11 | 30 | 5.84 | 1 | 10 | 60 | 15.1 |
Min, minimum; Max, maximum; AM10, alfaxalone-midazolam 10 mg/mL; AM40, alfaxalone-midazolam 40 mg/mL; SSMV, steady-state minute volume; AMV, accumulated minute volume.